CareLit · DOI-Nachweis · Aktuelle Neurologie
Systemic and intraventricular chemotherapy with deferred radiotherapy for primary central nervous system lymphoma (PCNSL): final report of a pilot and phase II study
DOI 10.1055/s-2005-919260
Bibliografische Angaben
Nachweis in CareLit
Autor:innenH Pels, I.G.H Schmidt-Wolf, A Glasmacher, U Schlegel
ZeitschriftAktuelle Neurologie
Ausgabe10/2005
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Purpose: To evaluate response rate, response duration, overall survival, and toxicity in PCNSL after systemic and intraventricular chemotherapy with deferred radiotherapy. Patients and Methods: From 09/1995 to 04/2002, 88 consecutive patients with PCNSL (median age 62 years) were enrolled in a pilot/phase II study evaluating high-dose methotrexate (MTX) (cycles 1,2,4,5) and cytarabine (ara-C) (cycles 3,6) based syst…
Zitieren
Zitierempfehlung
H Pels, I.G.H Schmidt-Wolf, A Glasmacher, U Schlegel (2005) Systemic and intraventricular chemotherapy with deferred radiotherapy for primary central nervous system lymphoma (PCNSL): final report of a pilot and phase II study. Aktuelle Neurologie (10). https://doi.org/10.1055/s-2005-919260
Mit CareLit weiterarbeiten